clinical_trials
Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial
Confidence95·multiple reportsImportance97NP-EVT-20261112-657BFC6
Nature Medicine, Published online: 12 November 2026; doi:10.1038/s41591-026-04712-z In a prespecified companion study (BMT CTN 1801) of the randomized phase 3 BMT CTN 1703 trial comparing two common GVHD prophylaxis regimens, microbiome diversity at engraftment did not associate with non-relapse mortality, but secondary analyses found baseline microbiome diversity was associated with clinical outcomes.
Read the original at the primary source
Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial
Ami S. Bhatt · 11/12/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —